
一、个人简介
陈建,男,安徽中医药大学中西医结合学院,副研究员,硕士生导师。2020年4月于中国科学技术大学获理学博士学位;2022年5月至2025年4月在中国科学院合肥物质科学研究院健康与医学技术研究所从事博士后研究。已发表SCI论文30余篇,包括Nature Communications,Oncogene,Cell Proliferation等,主持国家自然科学基金、安徽省高等学校自然科学基金等科研项目。担任等杂志审稿人。获安徽省中医药科学技术一等奖、二等奖,中国分析测试协会标记免疫分析专业委员会2019学术峰会青年优秀论文奖和第八届安徽省自然科学优秀学术论文二等奖各1项。
二、研究领域
针对严重影响人民生命健康的重大疾病,如恶性肿瘤,运用多组学技术,(1)阐释肿瘤证候生物学基础,解析方药量效关系;(2)开发不同生理病理状态下的类器官模型及共培养体系,建立癌症治疗疗效评估平台,挖掘合理的临床诊疗新标志物和新策略。
三、研究成果
1. 代表性论文
(1) Dong JX#, Chen J#, Pan H#, Hu C, Zhou J, Kong S, Yin C, Peng J, Ma J, Wang F, Wei DD, Zhang YW, Wang W, Ma K*, Jiang Y*, Jiang YY*. TEAD1 super-enhancer-mediated transcriptional dysregulation confers vulnerability in nasopharyngeal carcinoma. Cell Prolif. 2026, DOI: 10.1111/cpr.70301.
(2) Wang F#, Li J, Hu B, Tang M, Chen J*. Antiproliferative effects of pachymic acid on thyroid cancer cells and characterization of its metabolites. J Pharm Biomed Anal. 2026, 277: 117518.
(3) Kong S#, Pan H#, Zhang YW#, Wang F, Chen J, Dong J, Yin C, Wu J, Zhou D, Peng J, Ma JB, Zhou J, Ge D, Lu Y, Wei DD, Fang J, Han W, Shen C, Koeffler HP, Wang B*, Jiang Y*, Jiang YY*. Targeting super-enhancer associated oncogene-ALDH3A1 enhances ferroptosis sensitivity in squamous cancer. Oncogene. 2025, 44(15): 1037-1050.
(4) Jiang Y#, Zheng YY#, Zhang YW#, Kong S#, Dong J, Wang F, Ziman B, Gery S, Hao JJ, Zhou D, Zhou J, Ho AS, Sinha UK, Chen J, Zhang S, Yin C, Wei DD, Hazawa M, Pan H, Lu Z, Wei WQ, Wang MR, Koeffler HP, Lin DC*, Jiang YY*. Reciprocal inhibition between TP63 and STAT1 regulates anti-tumor immune response through interferon-γ signaling in squamous cancer. Nat Commun. 2024, 15(1): 2484.
(5) Jiang Y#, Zhao H#, Kong S, Zhou D, Dong J, Cheng Y, Zhang S, Wang F, Kalra A, Yang N, Wei DD, Chen J, Zhang YW, Lin DC*, Meltzer SJ*, Jiang YY*. Establishing mouse and human oral esophageal organoids to investigate the tumor immune response. Dis Model Mech. 2024, 17(1): dmm050319.
(6) Chen J*, Li J, Wang F, Ge R, Wang L, Huang J*. Metabolites profiling of liquiritin in acute myocardial infarction model rat after intragastric administration by an information dependent acquisition- mediated UHPLC–MS/MS method. Biomed Chromatogr. 2024, 38(8): e5933.
(7) Li J, Ge R, Wang F, Gu J, Zuo M, Tang T, Ge X, Niu Y, Wang L, Huang J*, Chen J*. Pharmacokinetic evaluation of 24 representative components of Ling‐Gui‐Zhu‐Gan decoction in acute myocardial infarction model rats via a validated ultrahigh‐performance liquid chromatography–tandem mass spectrometry method [J]. Rapid Commun Mass Spectrom, 2023, 37(19): e9620.
(8) Chen J#, Hou H, Chen H, Luo Y, He Y, Wang H, Deng H, Zhang L, Zhang Y, Liu H, Liu Y, Wang A, Hu Q. Quantitation of serum pregnanediol-3-glucuronide level in different endocrine statuses by LC-MS/MS, J Pharm Biomed Anal. 2020, 184: 113171.
(9) Chen J#, Hu Q, Hou H, Wang S, Zhang Y, Luo Y, Chen H, Deng H, Zhu H, Zhang L, Liu H, Wang A, Liu Y. Metabolite analysis-aided diagnosis of papillary thyroid cancer. Endocr Relat Cancer. 2019, 26(12): 829-841.
(10) Chen J#, Hou H, Chen H, Luo Y, He Y, Zhang L, Zhang Y, Liu H, Zhang F, Liu Y, Wang A, Hu Q. Identification of β-hydroxybutyrate as a potential biomarker for female papillary thyroid cancer. Bioanalysis, 2019 11(6): 461-470.
(11) Chen J#, Hou H, Chen H, Luo Y, Zhang L, Zhang Y, Liu H, Zhang F, Liu Y, Wang A, Hu Q. Urinary metabolomics for discovering metabolic biomarkers of laryngeal cancer using UPLC-QTOF/MS, J Pharm Biomed Anal. 2019, 167: 83–89.
(12) Chen J#, Wu H, Xu GB, Dai MM, Hu SL, Sun LL, Wang W, Wang R, Li SP, Li GQ. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies. J Pharm Biomed Anal. 2015, 108: 122-128.
(13) Chen J#, Wu H, Dai MM, Li H, Chen JY, Hu SL. Identification and distribution of four metabolites of geniposide in rats with adjuvant arthritis. Fitoterapia. 2014, 97:111-21.
四、联系方式
邮箱:jchen0222@163.com